As communicated by Little et al (1), removing steroid injections as a legitimate treatment option for a large cohort of patients does not seem a measured or responsible option.

This prospective service evaluation aims to quantify risk associated with any musculo-skeletal steroid injection during the pandemic.

Collaborators will be asked to input information on patient demographics, background Covid risk and steroid injection specifics. At follow up and at 4-6 weeks complications and Covid specific outcomes will be recorded.

Yellow card reporting and Covid consent process is also reported. In this way clinicians can be safe that they are monitoring outcomes appropriately, in line with national guidance, and that in due course information on local steroid safety will be available.

Register here to become a collaborator on the study.